Notch inhibition overcomes resistance to tyrosine kinase inhibitors in EGFR-driven lung adenocarcinomaEmilie Bousquet Mur(Université de Montpellier), Antonio Maraver(Inserm)Journal of Clinical InvestigationOctober 31, 201910.1172/jci126896Cited by 51SaveCiteExport RISWatch citationsRelated PapersGeneration and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance|Cancers|2021|10NOTCH1 intracellular domain stabilization by MDM2 plays a major role in NSCLC response to platinum|EMBO Molecular Medicine|2026|0